October 30, 2025
Breakthrough T1D Launches “See T1D”, a Nationwide Ad Campaign Spotlighting Life with Type 1 Diabetes in Honor of National Diabetes Awareness Month
October 30, 2025
Breakthrough T1D Applauds Launch of Lilly’s Phase 3 Clinical Trials
October 16, 2025
Breakthrough T1D Congratulates Civica on Launch of its First Low-Cost, Long-Acting Insulin
October 7, 2025
DEKA Research & Development Completes Acquisition of Diatech Diabetes Core Assets and IP
October 1, 2025
Breakthrough T1D Kicks Off Fall Walks to Celebrate Community and Raise Funds for Type 1 Diabetes Research
September 25, 2025
Breakthrough T1D, Lupus Research Alliance, and National Multiple Sclerosis Society Award Recipients of First Common Mechanisms of Autoimmunity Insight Award
September 19, 2025
Breakthrough T1D Encouraged by Results of Clinical Trial Demonstrating Effectiveness of Existing Drug in New-Onset Type 1 Diabetes
September 17, 2025
Cirius Therapeutics, Breakthrough T1D and UVA Health Collaborate on Phase 2 Study of MPC Inhibitor CIR-0602K in Type 1 Diabetes
August 14, 2025
Breakthrough T1D-Authored Paper Paves the Way for Beta Cell Replacement Therapies on the Path to Cures for Type 1 Diabetes
August 7, 2025
Governor Glenn Youngkin Announces $3 Million Grant to Support Civica’s Affordable Insulin Programs
